Overexpression of LAPTM4B: an independent prognostic marker in breast cancer. - Wikidata - awgldk - TriplyDB

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

http://www.wikidata.org/entity/Q44123654

about

Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer Integration of mRNA expression profile, copy number alterations, and microRNA expression levels in breast cancer to improve grade definition.Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expression LAPTM4B Gene Expression and Polymorphism as Diagnostic Markers of Breast Cancer in Egyptian Patients.Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer.LAPTM4B-35 protein is a weak tumor-associated antigen candidate.LAPTM4B: an oncogene in various solid tumors and its functions.Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.Association between LAPTM4B gene polymorphism and prostate cancer susceptibility in an Iranian population.Translationally controlled tumor protein in prostatic adenocarcinoma: correlation with tumor grading and treatment-related changes.Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population.LAPTM4B-35 is a novel prognostic factor for glioblastoma.Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma.Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.

P2860

Q28541215-B3E1816B-60F0-4387-94F8-891B81CA7FAE Q33670486-0D473A02-78C4-418F-9CD9-BC73523EA428 Q35092377-3B38EF24-82FA-4AEE-8F17-B41EC7DB1E2D Q35304103-850539EF-BF5D-418A-B4F6-7A15C09B8819 Q35742473-A6FC07D4-20FB-4C81-9C4E-7392218FAEEC Q37041338-C7E00EF2-FDBA-43A6-9039-1EBB419954F2 Q37367755-0DC488A8-D656-471D-A81A-8CE43B053068 Q37434480-5553690B-3962-4B75-911F-9C200BE08837 Q37510652-9DCD8AD6-586D-4000-A53A-B1A16A4CDCFA Q37636606-1F6E282C-D876-4311-A934-58CCB5A2D1AF Q38801879-D3440E8E-C059-483D-81B8-0B959D80EB76 Q38845980-04371012-B6DD-4238-BA9D-6B290AC27612 Q41016802-29E761DC-99C3-4A68-8F27-29570DEEAE78 Q41401802-62165ED1-3C4E-47C3-9BF6-95561B237AF4 Q42351255-71780A61-D16D-446F-A57B-C741A40DD932 Q43125303-ABF06DFE-C76A-438E-B742-9C5F02E83407 Q46156792-72C2DC65-3C9C-4582-830F-44CA20ECAA12 Q48342411-D8E0042C-E5BD-478F-A50B-E1EBBBAC4D24 Q48509293-6ACCD297-AC33-4A7D-A991-A77DD06652C1 Q50942673-51371BC8-6035-4286-8E76-075F37A52B05 Q54962725-8C1E4D7E-82C5-405A-95FC-5AC990AD86F7

P2860

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

http://www.wikidata.org/entity/Q44123654

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@en

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@nl

type

label

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@en

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@nl

prefLabel

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@en

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@nl

P1433

Q44123654-BA23D397-D7CB-4C2F-83E4-AF073F23E690

P1476

Q44123654-BBD8BDA2-C4BF-419F-9533-4159EDA84740

P2093

Q44123654-70F9B0CA-7AE2-4C94-B558-4DB274D5A9B1

Q44123654-9CC96023-FDE0-4D49-B0C9-ECB30F200A61

Q44123654-CC6791E0-F3BA-4CE1-B1DB-46BA291348E7

Q44123654-CD64513D-0E21-4DED-9422-0F70E941A49F

Q44123654-D24B5915-2B62-4291-BA74-4A94A18337F0

Q44123654-DF9364B3-D1A6-4C81-866C-364AF0E5A5EE

P2860

Q44123654-0082BE29-3F1B-42D2-BE12-1130DE458EF5

Q44123654-33383A8E-46A5-45DF-B5E3-E4878BF88574

Q44123654-4132130B-99F4-4DCA-902F-309ABFBBF3BA

Q44123654-4F6D1D59-7B7F-439D-867E-2F8864461D10

Q44123654-5D7EFCAC-05FB-41D0-9796-8B98D79BB77A

Q44123654-66B865B3-52F2-4F64-AD9E-0453E5860F5C

Q44123654-7D6D6B41-2F8B-47C8-B713-8AB0D6DD3394

Q44123654-919283C1-5093-4CED-AE8E-D788AC0A76CE

Q44123654-B52AE388-F82C-47E1-8B63-AFDBE5A48BAE

Q44123654-B935C6EB-A9DA-4B6D-8493-B13159445432

P2888

Q44123654-0F1BAFDA-A795-4D9D-A08F-BA9EABD03B4C

P304

Q44123654-D93521E2-85BA-4395-881A-1080E760BBC9

P31

Q44123654-2CAF887C-E2E8-467C-8974-BAF5F7BB6671

P356

Q44123654-1054088B-2158-4D56-98F4-174C671E8B9D

P433

Q44123654-6E0F7902-719F-4A79-BB45-E2DF13E059C7

P478

Q44123654-0EE4195C-7E41-4AEF-B120-1B4E0A08C5E5

P577

Q44123654-96D83DBE-3D04-422E-B73F-EF4EE480F007

P5875

Q44123654-B2350BBF-DBAA-4BC5-9946-5D9D56F7C87E

P698

Q44123654-FCFA5286-A0CD-4816-9EDA-BEA67366F30A

P921

Q44123654-82F6CEB3-7970-49A9-A328-091606B833DC

P356

S00432-012-1368-Y

P1433

Journal of Cancer Research and Clinical Oncology

P1476

Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.

@en

P2093

Hongbin Wang

http://www.w3.org/2001/XMLSchema#string

Jinsong Wang

http://www.w3.org/2001/XMLSchema#string

Min Xiao

http://www.w3.org/2001/XMLSchema#string

Shusheng Jia

http://www.w3.org/2001/XMLSchema#string

Yuanxi Huang

http://www.w3.org/2001/XMLSchema#string

Zhigao Li

http://www.w3.org/2001/XMLSchema#string

P2860

LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer

The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy

Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.

Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.

Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression.

Prognostic markers in triple-negative breast cancer.

Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.

Overexpression of LAPTM4B-35 in cervical carcinoma: a clinicopathologic study.

P2888

s00432-012-1368-y

P304

661-667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-012-1368-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234069802

http://www.w3.org/2001/XMLSchema#string

P698

23292099

http://www.w3.org/2001/XMLSchema#string

P921